Literature DB >> 3614653

Motor neuron disease in the United States, 1971 and 1973-1978: patterns of mortality and associated conditions at the time of death.

M Leone, V Chandra, B S Schoenberg.   

Abstract

Mortality rates for deaths "due to" and "with" motor neuron disease are presented for the first time. Age-specific mortality rates increase with age until 70 to 74 years and then decline. There appear to be no major differences by race in the age-adjusted mortality rates, but these rates are higher for males both white and nonwhite. A case-control study of all deaths with amyotrophic lateral sclerosis (ALS) was conducted for deaths due to ALS in the year 1971. Conditions associated with ALS at the time of death include pneumonia and bronchopneumonia, symptoms referable to respiratory system, superficial injury to shoulder and upper arm, essential benign hypertension, chronic skin ulcer, and malnutrition. No association was found between ALS and malignancies, Parkinson's disease, or dementia.

Entities:  

Mesh:

Year:  1987        PMID: 3614653     DOI: 10.1212/wnl.37.8.1339

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

1.  Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950.

Authors:  A M Chancellor; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

Review 2.  Neuroepidemiology of amyotrophic lateral sclerosis: clues to aetiology and pathogenesis.

Authors:  G C Román
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-08       Impact factor: 10.154

3.  The association between cancer and amyotrophic lateral sclerosis.

Authors:  D Michal Freedman; Rochelle E Curtis; Sarah E Daugherty; James J Goedert; Ralph W Kuncl; Margaret A Tucker
Journal:  Cancer Causes Control       Date:  2012-10-23       Impact factor: 2.506

4.  The risk of amyotrophic lateral sclerosis after cancer in U.S. elderly adults: a population-based prospective study.

Authors:  D Michal Freedman; Jincao Wu; Sarah E Daugherty; Ralph W Kuncl; Lindsey R Enewold; Ruth M Pfeiffer
Journal:  Int J Cancer       Date:  2014-02-28       Impact factor: 7.396

5.  Utility of Scottish morbidity and mortality data for epidemiological studies of motor neuron disease.

Authors:  A M Chancellor; R J Swingler; H Fraser; J A Clarke; C P Warlow
Journal:  J Epidemiol Community Health       Date:  1993-04       Impact factor: 3.710

6.  Risk factors for motor neuron disease: a case-control study based on patients from the Scottish Motor Neuron Disease Register.

Authors:  A M Chancellor; J M Slattery; H Fraser; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-11       Impact factor: 10.154

7.  Infection of the central nervous system, sepsis and amyotrophic lateral sclerosis.

Authors:  Fang Fang; Honglei Chen; Karin Wirdefeldt; Lars-Olof Ronnevi; Ammar Al-Chalabi; Tracy L Peters; Freya Kamel; Weimin Ye
Journal:  PLoS One       Date:  2011-12-27       Impact factor: 3.240

Review 8.  Pain Phenotypes in Rare Musculoskeletal and Neuromuscular Diseases.

Authors:  Anthony Tucker-Bartley; Jordan Lemme; Andrea Gomez-Morad; Nehal Shah; Miranda Veliu; Frank Birklein; Claudia Storz; Seward Rutkove; David Kronn; Alison M Boyce; Eduard Kraft; Jaymin Upadhyay
Journal:  Neurosci Biobehav Rev       Date:  2021-02-10       Impact factor: 9.052

9.  Race/ethnicity, socioeconomic status, and ALS mortality in the United States.

Authors:  Andrea L Roberts; Norman J Johnson; Jarvis T Chen; Merit E Cudkowicz; Marc G Weisskopf
Journal:  Neurology       Date:  2016-10-14       Impact factor: 9.910

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.